BioRestorative Therapies Financials - Benzinga

BioRestorative Therapies Inc

BRTXNASDAQ

Trade with Public

Trade with Public

$0.1977

-0.0047-2.32%

Last update: Sep 1, 12:04 PM

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

BioRestorative Therapies Financials

BioRestorative Therapies (BRTX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
BioRestorative Therapies Q4 EPS $(0.32) Misses $(0.30) Estimate, Sales $19.600K Miss $520.000K Estimate

BioRestorative Therapies (NASDAQ:BRTX) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.30) by 4.92 percent. This is a 60 percent decrease over losses of $(0.20) per share

Benzinga Newsdesk

S&P 500 Falls Over 1%; American Electric Power Shares Gain After Upbeat Earnings

Avi Kapoor

PRO
BioRestorative Therapies Q3 EPS $(0.33) Beats $(0.36) Estimate, Sales $11.800K Miss $460.000K Estimate

BioRestorative Therapies (NASDAQ:BRTX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.36) by 8.33 percent. This is a 153.85 percent decrease over losses of $(0.13) per

Benzinga Newsdesk

Earnings Scheduled For November 12, 2025

Benzinga Insights

Earnings Outlook For BioRestorative Therapies

Benzinga Insights

PRO
BioRestorative Therapies Q2 EPS $(0.30) Beats $(0.37) Estimate, Sales $303.000K Miss $340.000K Estimate

BioRestorative Therapies (NASDAQ:BRTX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.37) by 18.92 percent. This is a 40 percent increase over losses of $(0.50) per share

Benzinga Newsdesk